Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B45142fc31d9b0f46ae1f86023e0b1e4b> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B45142fc31d9b0f46ae1f86023e0b1e4b NCIT_P378 "NCI" @default.
- B45142fc31d9b0f46ae1f86023e0b1e4b type Axiom @default.
- B45142fc31d9b0f46ae1f86023e0b1e4b annotatedProperty IAO_0000115 @default.
- B45142fc31d9b0f46ae1f86023e0b1e4b annotatedSource NCIT_C84866 @default.
- B45142fc31d9b0f46ae1f86023e0b1e4b annotatedTarget "An orally bioavailable small-molecule androgen receptor modulator and CYP17 lyase inhibitor with potential antiandrogen activity. Galeterone exhibits three distinct mechanisms of action: 1) as an androgen receptor antagonist, 2) as a CYP17 lyase inhibitor and 3) by decreasing overall androgen receptor levels in prostate cancer tumors, all of which may result in a decrease in androgen-dependent growth signaling. Localized to the endoplasmic reticulum (ER), the cytochrome P450 enzyme CYP17 (P450C17 or CYP17A1) exhibits both 17alpha-hydroxylase and 17,20-lyase activities, and plays a key role in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens." @default.